Слайд 2Clinical case
Patient X
Age: 18 years (June 1996)
Sex: female
Date of diagnosis: 09.2014
![Clinical case Patient X Age: 18 years (June 1996) Sex: female Date of diagnosis: 09.2014](/_ipx/f_webp&q_80&fit_contain&s_1440x1080/imagesDir/jpg/1163130/slide-1.jpg)
Слайд 3Clinical case
Diagnosis:
Hodgkin’s lymphoma, stage III A. Variant of nodular sclerosis,
![Clinical case Diagnosis: Hodgkin’s lymphoma, stage III A. Variant of nodular sclerosis,](/_ipx/f_webp&q_80&fit_contain&s_1440x1080/imagesDir/jpg/1163130/slide-2.jpg)
with affection cervical, supraclavicular, axillary, mediastinal, retroperitoneal lymphatic nodes.
Слайд 4Clinical case
Therapy
8 courses of chemotherapy according to the ABVD protocol (09.2014-
![Clinical case Therapy 8 courses of chemotherapy according to the ABVD protocol](/_ipx/f_webp&q_80&fit_contain&s_1440x1080/imagesDir/jpg/1163130/slide-3.jpg)
04.2015)
Result
partial effect:
Limphatic node biopsy - Hodgkin’s lymphoma cells
Слайд 5Belorussian Hematology and BMT Centre
19 - 28.05.2015 - courses of reinduction therapy
![Belorussian Hematology and BMT Centre 19 - 28.05.2015 - courses of reinduction](/_ipx/f_webp&q_80&fit_contain&s_1440x1080/imagesDir/jpg/1163130/slide-4.jpg)
DHAP
26.-29.06.2015 – DHAP
28.07-13.08.2015 – DHAP and 2 sessions of stem cells apheresis
Result
- partial remission
Слайд 6Belorussian Hematology and BMT Centre
13.11-01.12.2015
high-dose chemotherapy (BEAM) + autologous HSCT
СD34+
![Belorussian Hematology and BMT Centre 13.11-01.12.2015 high-dose chemotherapy (BEAM) + autologous HSCT](/_ipx/f_webp&q_80&fit_contain&s_1440x1080/imagesDir/jpg/1163130/slide-5.jpg)
4.12*106/kg
nucleated cells -6.63x 108/kg
Hematopoietic recovery: day +9
Слайд 8But…
November 2016 - Relapse (lesion of cervical, supraclavicular, mediastinal , retrocrural,
![But… November 2016 - Relapse (lesion of cervical, supraclavicular, mediastinal , retrocrural,](/_ipx/f_webp&q_80&fit_contain&s_1440x1080/imagesDir/jpg/1163130/slide-7.jpg)
paraaortal, retroperitoneal lymphatic nodes and soft tissues of the right lunq, thyroid) confermed by PET CT.
Слайд 12Further tactic?
Way #1 – monotherapy with Brentuximab
Way#2 – modified courses PCT with
![Further tactic? Way #1 – monotherapy with Brentuximab Way#2 – modified courses](/_ipx/f_webp&q_80&fit_contain&s_1440x1080/imagesDir/jpg/1163130/slide-11.jpg)
Brentuximab
(DHAP+Brentuximab,
Bendamustine+Brentuximab..?)
Way #3 – HD PCT and the second transplantation
Way #4 - your advises